Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

2.1K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
2.1K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

2.3K
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.3K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

1.1K
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

3.8K
Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
3.8K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

3.2K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
3.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reconstruction of 3D crystal growth from transmission optical microscopy images.

PNAS nexus·2026
Same author

Modeling Pharmaceutical Batch Cooling Crystallization Processes Using Computational Fluid Dynamics Coupled with a One-Dimensional Population Balance Model.

Crystal growth & design·2026
Same author

Molecular, Crystal, and Surface Chemistry of <i>p</i>‑Aminobenzoic Acid and the Interrelationship between Its Solution-Phase Crystallization and Solid-Form Selectivity: A Review.

Crystal growth & design·2025
Same author

Crystal Morphology and Associated Face-Specific Growth Kinetics of Tolfenamic Acid as a Function of Its Solution Crystallization Environment.

Crystal growth & design·2025
Same author

Structure, morphology and surface properties of α-lactose monohydrate in relation to its powder properties.

Journal of pharmaceutical sciences·2024
Same author

Deconstructing 3D growth rates from transmission microscopy images of facetted crystals as captured <i>in situ</i> within supersaturated aqueous solutions.

Journal of applied crystallography·2024
Same journal

Benefits, risks, and future prospectives of nanomaterials in sustainable agriculture: a review.

Nanotoxicology·2026
Same journal

Decoding silica nanoparticle toxicity: integrating machine learning, feature importance, rule extraction, and adsorption-uptake processes.

Nanotoxicology·2026
Same journal

Polystyrene nanoparticles and death of erythrocytes: does exposure induce eryptosis?

Nanotoxicology·2026
Same journal

Polystyrene nanoplastics promote tumor lung metastasis by inducing sodium overload in macrophages in an NMDAR-dependent way.

Nanotoxicology·2026
Same journal

Comparative entomotoxic effects of nanosilica and microsilica on <i>Crocidolomia pavonana</i> larvae.

Nanotoxicology·2026
Same journal

Gold-modified superparamagnetic iron oxide nanoparticles: Magnetic accumulation under flow conditions and toxicity evaluation in vitro and in vivo.

Nanotoxicology·2026
See all related articles

Related Experiment Video

Updated: Apr 24, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.0K

Nano(Q)SAR: Challenges, pitfalls and perspectives.

Ratna Tantra1, Ceyda Oksel, Tomasz Puzyn

  • 1National Physical Laboratory , Teddington, Middlesex , UK .

Nanotoxicology
|September 12, 2014
PubMed
Summary
This summary is machine-generated.

Developing reliable nano-(quantitative structure-activity relationship) [(Q)SAR] models for nanomaterial regulation requires improved experimental data quality. Addressing data gaps is crucial for advancing nano(Q)SAR and ensuring accurate categorization.

Keywords:
NanotoxicologyQSARreview

More Related Videos

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods
05:34

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

1.8K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

16.3K

Related Experiment Videos

Last Updated: Apr 24, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

2.0K
Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods
05:34

Applying Cheminformatics to Develop a Structure Searchable Database of Analytical Methods

Published on: June 6, 2025

1.8K
In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
05:47

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Published on: August 28, 2019

16.3K

Area of Science:

  • Environmental Science
  • Toxicology
  • Materials Science

Background:

  • Regulatory frameworks like REACH promote intelligent testing strategies, including quantitative structure-activity relationships [(Q)SAR], for chemical categorization.
  • Nano(Q)SAR models are being developed to assess nanomaterials, but their application faces significant challenges compared to traditional (Q)SAR for chemicals.

Purpose of the Study:

  • This article identifies key challenges and limitations in the development and application of nano(Q)SAR models for nanomaterial categorization.
  • The study aims to highlight research gaps crucial for establishing reliable nano(Q)SAR predictions for regulatory use.

Main Methods:

  • The study reviews existing literature and identifies barriers in the nano(Q)SAR research framework.
  • Analysis focuses on the quality of experimental data, practical guidelines for model development, and the need for standardization in regulatory activities.

Main Results:

  • Three primary barriers hinder nano(Q)SAR implementation: insufficient quality of experimental data, lack of practical development guidelines, and absence of standardized regulatory harmonization.
  • The quality, consistency, and accessibility of experimental data are paramount for effective nano(Q)SAR modeling, more so than data quantity.

Conclusions:

  • Improving the quality of experimental data is the most critical and immediate need for advancing nano(Q)SAR.
  • Addressing these identified barriers is essential for the successful uptake of nano(Q)SAR in regulatory decision-making for nanomaterials.